Example: Heart Attack

Search clinical trials for: machine-learning algorithm

Total 10000 results

NCT00546273

Completed

Clinical Trial to Study 4 Different Doses of the Vaccine RUTI in Healthy Volunteers

Tuberculosis | Latent Tuberculosis Infection
NCT00152802

Unknown

Pneumonia Vaccine in Liver Transplant Recipients: a Booster Strategy Using a Conjugate Vaccine

Transplant
NCT04232943

Completed

Inactivated Poliovirus Vaccine (IPV) With or Without E.Coli Double Mutant Heat-Labile Toxin (dmLT) Challenge Study in Healthy Adults

Polio
NCT02547493

Completed

Vaccination Against Pneumococcal in Naïve Abatacept Rheumatoid Arthritis Patients (VACINA)

Rheumatoid Arthritis
NCT02425241

Completed

Depletion of Serum Amyloid P Component to Enhance the Immune Response to DNA Vaccination (HIV-CORE003)

HIV
NCT04368429

Completed

Study of a Quadrivalent Meningococcal Conjugate Vaccine as a Single Dose Compared With a Single Dose of a Meningococcal Reference Vaccine in Children, Adolescents, and Adults 2 to 55 Years of Age

Meningococcal Immunisation (Healthy Volunteers)
NCT05386810

Completed

Safety of Sabin Inactivated Poliovirus Vaccine in Adults, Children and Infants and Lot Consistency Immunogenicity, and Safety of the msIPV in 2 Months Old Infants

Poliomyelitis
NCT02192515

Completed

A Study of APD356 (Lorcaserin) in Healthy Japanese Adult Subjects

Healthy Subjects
NCT02580942

Completed

Efficacy Study of Acupoint Sticking in Summer to Treat Asthma

Asthma
NCT03893747

Completed

Immunity and Safety of Inactivated Enterovirus 71 Vaccine Post-marketing Among Children Aged 6-35 Months in China

Hand, Foot and Mouth Disease
NCT02140047

Completed

Exploratory Clinical Study of MT-2301

Haemophilus Influenza Type b
NCT03698279

Completed

Safety and Immunogenicity of Different Dosages of High-Dose Quadrivalent Influenza Vaccine in Children 6 Months to 17 Years of Age (QHD04)

Influenza
NCT02097849

Completed

Vaccination Response in Tecfidera-Treated Versus Interferon-Treated Participants With Relapsing Forms of Multiple Sclerosis.

Relapsing Forms of Multiple Sclerosis
NCT04904549

Terminated

Study of Monovalent and Bivalent Recombinant Protein Vaccines Against COVID-19 in Adults 18 Years of Age and Older (VAT00008)

COVID-19
NCT05294588

Completed

Efficacy of Immunization With 4C-MenB in Preventing Experimental Urethral Infection With Neisseria Gonorrhoeae

Gonorrhea Male
NCT07373301

Not yet recruiting

Phase IIa/b Trial of PvCS/Montanide ISA-51 Malaria Vaccine in Adults in Chocó, Colombia (PvCS/M51)

Plasmodium Vivax Infection | Plasmodium Vivax Malaria | Malaria Prevention
NCT05655182

Recruiting

A Study of BLB-201 RSV Vaccine in Infants and Children

Respiratory Syncytial Virus Infections
NCT06143878

Active, not recruiting

A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis

Plaque Psoriasis
NCT06220604

Active, not recruiting

A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis (ICONIC-ADVANCE 2)

Plaque Psoriasis
NCT04563533

Completed

Clinical Trial of Quadrivalent Recombinant Norovirus Vaccine (Pichia Pastoris)

Acute Gastroenteritis
NCT04841369

Completed

Phase III Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above (PICTPCV13i)

Pneumococcal Infections | Bacterial Infections | Streptococcal Infections
NCT03493919

Completed

A Sourcing Study to Collect Human Blood Samples From Healthy Adults

Meningitis, Meningococcal
NCT03553940

Completed

H3N2 M2SR in Pediatric Population

Influenza | Influenza Immunisation
NCT04689191

Unknown

A Phase III Clinical Trial of the Group A and C Meningococcal Polysaccharide Vaccine

Meningitis, Meningococcal
NCT00435812

Completed

Safety and Efficacy of HEPLISAV™ Hepatitis B Virus Vaccine Compared With Engerix-B® Vaccine

Hepatitis B
NCT02117934

Completed

Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine

Healthy
NCT02676895

Completed

A Study of the Safety and Immune Response of 2 Doses of a New Shigella Vaccine in Kenyan Adults

Shigella Sonnei Infection
NCT03206255

Completed

Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls

Cervical Cancer | Cervical Intraepithelial Neoplasia | Vaginal Intraepithelial Neoplasia | Vulvar Intraepithelial Neoplasia | Persistent Infection
NCT02562508

Completed

A Bridging Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls

Cervical Cancer | Cervical Intraepithelial Neoplasia | Vaginal Intraepithelial Neoplasia | Vulvar Intraepithelial Neoplasia | Persistent Infection
NCT00096629

Completed

Vaccine Therapy in Treating Patients With Kidney Cancer

Kidney Cancer
NCT01784874

Completed

Comparison of Purified Vero Rabies Vaccine, Serum Free With Human Diploid Cell Vaccine in Pre-exposure Use

Rabies
NCT01526551

Completed

A Study to Compare the Impact of a School Based HPV Program on Vaccination Uptake and Completion Rates

Human Papillomavirus
NCT00491985

Completed

Safety and Immunogenicity of 2 Formulations of an Intramuscular A/H5N1 Pandemic Influenza Vaccine in Children

Influenza | Orthomyxoviridae Infections | Influenza A Virus Infection
NCT01579448

Completed

Evaluation of a Boosting Regimen With Oral Cholera Vaccine (Boost)

Cholera
NCT01451086

Completed

Safety and Immunogenicity of 23-valent Pneumococcal Polysaccharide Vaccine in 2 to 70 Years Old Healthy People in China

Healthy
NCT00764634

Completed

Double Blind, Safety and Immunogenicity Study of Recombinant Botulinum Vaccine A/B

Botulism Vaccine
NCT07011927

Recruiting

Extra-cochlear Electrode Placement at the Post-auricular Vagus Nerve in Cochlear Implantation

Hearing Loss
NCT04194970

Completed

Monitoring of Weight Bearing Protocols Via Mobile Application and Pressure Sensors.

Osteochondral Lesion of Talus
NCT06940141

Recruiting

Rademikibart Add-on Treatment of an Acute Asthma Exacerbation (Seabreeze STAT Asthma)

Asthma Acute
NCT06882447

Not yet recruiting

A Study of QL1706 Combined with Nine HPV Vaccine As First-line Treatment for Persistent, Recurrent or Metastatic Cervical Cancer (QL1706)

Cervical Cancer Stage IVB
NCT06632457

Recruiting

LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

Metabolic Dysfunction Associated Steatohepatitis
NCT06470165

Not yet recruiting

Priority-Matching Correction Technique in Degenerative Lumbar Scoliosis (PMCTDLS)

Scoliosis | Degenerative Scoliosis | Degenerative Lumbar Disease
NCT05216484

Recruiting

Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) in Adults Aged 18 Years and Above (6 Months After Two Doses)

SARS-CoV-2 Infection
NCT05163652

Recruiting

Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) Based on Different COVID-19 Inactivated Vaccine in Adults Aged 18 Years and Above

SARS-CoV-2 Infection
NCT04825340

Not yet recruiting

To Explore a Bridging Index for the Effectiveness of the Clinical Trial

Randomized
NCT05683457

Active, not recruiting

A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Allogenic Hematopoietic Cell Transplantation (HCT) Participants.

Cytomegalovirus Infection
NCT06190509

Active, not recruiting

Assessing the Safety, Immune Response, and Early Efficacy of a Candida Vaccine in Women With Recurrent Vulvovaginal Candidiasis: A Randomized Controlled Study

Recurrent Vulvovaginal Candidiasis
NCT06614725

Completed

A Study in India on the Immune Response and Safety of a Respiratory Syncytial Virus (RSV) Older Adults (OA) Vaccine When Given to Older Adults 60 Years of Age and Above and Adults 50-59 Years of Age at Increased Risk (AIR) of Respiratory Syncytial Virus Lower Respiratory Tract Disease (RSV-LRTD)

Respiratory Syncytial Virus Infections
NCT04079166

Active, not recruiting

SCIB1 and iSCIB1+ in Melanoma Patients Receiving Nivolumab With Ipilimumab or SCIB1 With Pembrolizumab (The SCOPE Study)

Melanoma (Skin) | Malignant Melanoma | Melanoma Stage IV | Melanoma Stage III
NCT05085366

Terminated

A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age

Cytomegalovirus Infection

Search clinical trials for: machine-learning algorithm

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations